Kintara Therapeutics, Inc. (KTRA)
NASDAQ: KTRA · IEX Real-Time Price · USD
0.245
+0.028 (12.71%)
At close: Jul 26, 2024, 4:00 PM
0.248
+0.003 (1.31%)
After-hours: Jul 26, 2024, 6:47 PM EDT
Kintara Therapeutics Market Cap
Kintara Therapeutics has a market cap or net worth of $13.54 million as of July 26, 2024. Its market cap has increased by 61.17% in one year.
Market Cap
13.54M
Enterprise Value
6.85M
1-Year Change
61.17%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since February 22, 2013, Kintara Therapeutics's market cap has increased from $6.70M to $13.54M, an increase of 102.07%. That is a compound annual growth rate of 6.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 12.00M | 1,900.00% |
| Dec 29, 2023 | 600.00K | -94.59% |
| Dec 30, 2022 | 11.10M | -55.24% |
| Dec 31, 2021 | 24.80M | -21.52% |
| Dec 31, 2020 | 31.60M | 300.00% |
| Dec 31, 2019 | 7.90M | 2.60% |
| Dec 31, 2018 | 7.70M | -67.23% |
| Dec 29, 2017 | 23.50M | -29.22% |
| Dec 30, 2016 | 33.20M | -10.51% |
| Dec 31, 2015 | 37.10M | 34.91% |
| Dec 31, 2014 | 27.50M | 21.68% |
| Dec 31, 2013 | 22.60M | 237.31% |
| Feb 22, 2013 | 6.70M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psychemedics | 13.06M |
| Addex Therapeutics | 12.99M |
| Purple Biotech | 12.96M |
| Avalo Therapeutics | 12.94M |
| BriaCell Therapeutics | 12.89M |
| Novo Integrated Sciences | 12.77M |
| Ontrak | 12.71M |
| Lumos Pharma | 12.58M |